Skip to main content

Table 2 The neutralization potencies of YG8–1, YG8–2, and YG8–3 toward rabbit RBCs treated with HlgAB and HlgBC. IC50 expressed as mAb:toxin ratio

From: Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus

toxin

HlgAB

HlgBC

mAbs

YG8–1

0.10

0.28

YG8–2

0.12

0.27

YG8–3

0.26

0.21